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Abstract 
Iron homeostasis in the human body is maintained primarily through regulation of iron absorption in 
the duodenum. The liver peptide hepcidin plays a central role in this regulation. Additionally, 
expression and functional control of certain components of the cellular iron transport machinery can 
be influenced directly by the iron status of enterocytes. The significance of this modulation, relative 
to the effects of hepcidin, and the comparative effects of iron obtained directly from the diet and or 
via the bloodstream are not clear. The studies described here were performed using Caco-2 cell 
monolayers as a model of intestinal epithelium, to compare the effects of iron supplied in 
physiologically relevant forms to either the apical or basolateral surface of the cells. Both sources of 
iron provoked increased cellular ferritin content indicating iron uptake from both sides of the cells. 
Supply of basolateral transferrin-bound iron did not affect subsequent iron transport across the 
apical surface but reduced iron transport across the basolateral membrane. In contrast, the apical 
iron supply led to subsequent reduction in iron transport across the apical cell membrane without 
altering iron export across the basolateral membrane. The apical and basolateral iron supplies also 
elicited distinct effects on the expression and subcellular distribution of iron transporters. These data 
suggest that, in addition to the effects of cellular iron status on the expression of iron transporter 
genes, different modes and direction of iron supply to enterocytes can elicit distinct functional 
effects on iron transport.  
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Introduction 
Iron is an essential component for many cellular processes including oxygen transport, energy 
production and numerous enzymatic reactions. Commonly, iron functions as an electron 
acceptor/donor through its capacity to convert between the ferric and ferrous forms. However, this 
same property makes excess iron toxic, with free iron having the potential to elicit severe oxidative 
stress (Kruszewski 2003). Thus tight regulation of iron homeostasis with appropriate storage of body 
iron is vital for maintenance of health.  
 
Since humans lack a defined regulated mechanism for active iron excretion, homeostasis is 
sustained primarily through regulation of intestinal iron absorption from the diet (Frazer and 
Anderson 2005). As crypt cells migrate to the villi of the intestinal epithelium, they differentiate into 
mature absorptive enterocytes (King et al. 1981). In the duodenum, this differentiation process 
includes the co-ordinated activation of the cellular machinery for absorption of iron from dietary 
sources and for iron transport into the bloodstream; increasing expression of the genes that form 
the individual components of the iron transport system including the ferric reductase duodenal 
cytochrome b reductase 1, divalent metal ion transporter 1 (DMT-1), ferroportin (FPN) and 
hephaestin (Canonne-Hergaux et al. 1999; Donovan et al. 2000; Vulpe et al. 1999). The expression 
of these genes and the activity of their products are regulated also by body iron status/demand as 
well as by dietary iron supply (Canonne-Hergaux et al. 1999; Collins et al. 2005; Frazer et al. 2003; 
Gunshin et al. 2001; Gunshin et al. 1997; Millard et al. 2004). This indicates that the intestinal 
epithelium possesses mechanisms for sensing whole body iron requirements and it has been widely 
postulated that feedback control of iron absorption by the intestinal epithelium is achieved via 
signalling molecules present in plasma: the so-called stores regulator and erythropoeitic regulator 
(Roy and Enns 2000).  
 
Ferritin, transferrin (Tf) and serum Tf receptor have all been put forward previously as possible 
candidates for the stores regulator (Roy and Enns 2000).  However, the liver peptide hepcidin is 
now widely accepted as the main stores regulator (Frazer and Anderson 2005; Ganz and Nemeth 
2006). Expression and secretion of hepcidin from the liver is regulated by iron status and 
inflammation (Mazur et al. 2003; Nemeth et al. 2004a; Nicolas et al. 2002). Hepcidin acts as a 
negative regulator of iron absorption by binding to and promoting the internalization and degradation 
of FPN, the iron transporter present on the basolateral membrane of enterocytes that is responsible 
for exporting iron from the epithelium into the blood stream (Nemeth et al. 2004b). Additionally, 
there is some evidence that hepcidin also may act to suppress iron absorption at the apical surface 
of the enterocytes (Brasse-Lagnel et al. 2011; Mena et al. 2008; Yamaji et al. 2004). 
 
However, a model for regulation of intestinal iron transport that involves hepcidin alone does not 
take into account other feedback control mechanisms that regulate iron homeostasis at the cellular, 
rather than whole body, level. Such mechanisms include the extensively characterized iron 
response protein (IRP) – iron response element (IRE) interactions, which act in an iron-sensitive 
manner at a post-transcriptional level to regulate expression of a number of the key genes involved 
in iron transport and cellular homeostasis (Lymboussaki et al. 2003; Menotti et al. 1998; 
Pantopoulos 2004). Additionally, some of these same genes, as well as genes that do not contain 
an IRE, may also be regulated in an iron-sensitive manner yet to be fully defined, which is 
independent of the IRP-IRE system (Han et al. 1999; Zoller et al. 2002). Intestinal epithelial cells are 
uniquely placed in this context since they can derive cellular iron both from the bloodstream, as for 
other tissues, and directly from dietary sources. Thus both sources have the potential to affect 
enterocyte iron status. Moreover, enterocytes need to strike a constant balance between 
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maintaining an appropriate supply of iron to meet the demands of the rest of the body whilst also 
ensuring adequate and appropriate iron supply for their own requirements.  
 
The studies described here were performed to test the hypothesis that, in addition to other somatic 
signals such as hepcidin, the supply of iron to enterocytes from the diet and the body contributes to 
the regulation of dietary iron absorption by influencing crypt cell and/or mature villus enterocyte iron 
status.  The Caco-2 model of intestinal epithelium was employed to compare effects of ferric 
nitrilotriacetate (NTA), supplied to the apical surface of the cells to mimic dietary iron, or  Tf-bound 
iron, supplied to the basolateral surface of the cells to mimic somatic iron, on the iron transport 
capacity of the cells and on the expression of iron transport machinery. The experiments were 
performed using cells grown on permeable supports in bicameral chambers during the process of 
cellular differentiation that occurs subsequent to the cells growing to confluence. These conditions 
were selected for the investigations since the differentiation process for Caco-2 cells shares many 
common themes with the changes that occur during the differentiation of crypt cells into mature 
absorptive enterocytes, including the co-ordinated up-regulation of the cellular iron transport 
machinery (Bedrine-Ferran et al. 2004; Fleet et al. 2003; Han et al. 1999; Sharp et al. 2002). 
Numerous previous studies have demonstrated that prior loading of Caco-2 cells with free iron, 
supplied to both the apical and basolateral sides of the cells, can affect subsequent iron uptake and 
transport (Arredondo et al. 1997; Sharp et al. 2002; Tallkvist et al. 2003). However, to our 
knowledge, this is the first study comparing the effects of supply of iron to Caco-2 cells specifically 
via apical or basolateral surfaces and in forms representative of those enterocytes would be 
exposed to in vivo.    
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Materials and methods 
 
Cell culture conditions 
Caco-2 cells were obtained from the American Type Culture Collection (Rockville, MD, USA) and 
used in all the experiments described here between passages 26 and 31. Cells were routinely 
cultured at 37°C in an incubator with a 5% CO2, 95% air atmosphere at constant humidity in 
Dulbecco’s Modified Eagle Medium (DMEM) containing 10% (v/v) fetal bovine serum (FBS), 100 
units/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine and 1% (v/v) non-essential amino 
acid solution (Sigma Aldrich, Poole, UK). The culture medium was refreshed every 2-3 days and 
cells passaged every 7 days. Iron-depleted FBS was prepared by treating FBS with Chelex®100 
chelating ion exchange resin (BioRad, Hemel Hempstead, UK) as described previously (Alvarez-
Hernandez et al. 1991). The iron concentration in the FBS prior to, and following, Chelex®100 
treatment was determined by atomic absorption spectrophometry using a Perkin Elmer Atomic 
Absorption Spectrophotometer Model 3300 (Fernandez and Kahn 1971).  
 
For all experiments, cells were seeded at a density of 30,000 cells/cm2 in 6- or 12-well Transwell® 
permeable support plates (Costar®, Corning Inc., New York, USA). The medium was refreshed 
every 2 to 3 days. Transepithelial electrical resistance (TEER) was monitored, using an EVOM2 
Epithelial Voltohmmeter (World Precision Instruments, Hitchin, UK), over subsequent days to 
confirm time to confluence and the permeability of the cell monolayers prior to experimental 
manipulations. On day 14 after seeding, the cells were transferred to medium containing the metal-
depleted FBS at 10% v/v both above and below the cells. To one set of the Transwells, 30 µM 
human iron-saturated Tf (holo-Tf from Sigma, Poole, UK) was added to the basolateral medium. To 
another set, 10 µM ferric NTA was added to the apical medium.  For controls, no additional source 
of iron was added. The media preparations were refreshed every 2 to 3 days for 1 week prior to 
performing ferritin, iron transport, mRNA and protein expression analyses on day 21. 
 
Ferritin analysis 
Ferritin concentrations in cell lysates were determined by enzymatic immunoassay using the Ramco 
Laboratories Spectro-Ferritin kit S-22 (ATI Atlas, Chichester, UK) according to the manufacturer’s 
instructions. Ferritin concentrations in the lysates were normalised against total protein content 
determined using the Micro BCA protein assay kit (Fisher Scientific UK Ltd, Loughborough, UK). 
 
Iron uptake and transport analysis 
For analysis of iron uptake and transport, the culture medium was removed and the cells washed 
with Hanks buffered salt solution (HBSS from Sigma, Poole, UK).  Transepithelial pH gradients were 
established essentially as described by Tandy and co-workers (Tandy et al. 2000), by adding HBSS 
(pH 7.4) to the basolateral chamber and PIPES buffered salt solution (identical in composition to 
HBSS except that the HEPES was replaced with PIPES and the pH adjusted to 6.5) to the apical 
chamber. Uptake was initiated by the addition to the apical chamber of 10 µM ferric NTA, containing 
sufficient 55Fe to give a final activity of 37 kBq/ml. The cells were placed in an incubator at 37 °C on 
an orbital shaker rotating at ≤80 rpm. After 2 hours, the apical and basolateral media were removed 
to separate tubes. The apical surface of the cells was washed twice with ice-cold HBSS and the 
wash solutions were pooled with the corresponding apical medium solutions. The apical surface of 
the cells was washed for a further 10 minutes with ice-cold 140 mM NaCl, 5 mM KCl, 10 mM PIPES, 
containing 5 mM sodium dithionite and 1 mM bathophrenanthroline disulphonic acid to ensure 
removal of any non-specifically bound surface iron (Glahn et al. 1995). This wash solution was 
removed and combined with the apical media and previous washes. The cells were lysed with 0.2 M 
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NaOH and the lysates neutralised with an equal volume of 0.2 M HCl. Portions of the apical medium 
(including wash solutions), basolateral medium and cell lysates were subjected to scintillation 
counting.  
 
Real time RT-qPCR analysis 
Prior to isolation of RNA, medium was removed from the TransWells and the cells were washed 
with HBSS. RNA isolation was performed using RNeasy mini kits (Qiagen, Crawley, UK) according 
to the manufacturer’s instructions and stored at -80 °C. Total RNA yield was determined using a 
NanoDrop® ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, USA) and RNA 
purity assessed by the ratio of absorbance at 260 and 280 nm. All samples had 260/280 
absorbance ratios greater than 1.8. Total RNA integrity was assessed using Agilent RNA6000nano 
LabChips® (Agilent Technology 2100 Bioanalyzer Version A.01.20 SI211). All samples had RIN 
scores greater than 8. 
 
Real-time RT-qPCR was performed using an ABI Prism 7300 or 7700 Sequence Detection System 
(Applied Biosystems) for each of 3 test genes (transferrin receptor-1 (TfR-1), DMT-1 and FPN) plus 
the reference gene RNA polymerase 2 polypeptide A (POLR2A) (Radonic et al. 2004). The primers 
and probes used for POL2RA were as described previously (Hurst et al. 2008). Primers and probes 
the other genes were designed using Primer Express Software (Applied Biosystems) with all 
amplicons designed to span intron-exon boundaries (Table 1). Sequence homology of selected 
oligomers was checked by NCBI BLAST search to ensure sequences were specific to target genes. 
The probes were labelled with a 5’ reporter dye, FAM (6-carboxyfluoroscein) and 3’ quencher dye, 
TAMRA (6-carboxytetramethylrhodamine). A one-step RT-qPCR reaction was employed for all 
assays. Real time RT-qPCR reactions were carried out in 96 well plates using Taqman® 1-step 
RTPCR mastermix reagent kits (Life Technologies, Paisley, UK) in a total volume of 25 µl/well with 
a final concentration of 100 nM of the probe and 200 nM of each of the forward and reverse primers. 
Test samples (10 ng of total RNA per reaction) were analysed by comparison with a standard curve, 
included on each plate, consisting of serial dilutions (80, 40, 20, 10 and 5 ng/well) of a pooled Caco-
2 RNA reference sample. The real time-PCR conditions were as follows: 48°C for 30 minutes, then 
95°C for 10 minutes, followed by 40 amplification cycles of 95°C for 15 s and 60°C for 1 minute. The 
data generated were analysed with ABI Taqman software. The r2 value for log linear fit of standard 
curves was >0.99 in all cases and the mean efficiency of amplification (based on the mean gradient 
of standard curves from four plates for each assay) was 91, 97, 94 and 97% for POL2RA, DMT-1, 
FPN and TfR-1, respectively.  Performance of each assay was tested to confirm non-interference of 
human genomic DNA. Within plate intra-assay variation, based on the average coefficient of 
variation for the triplicate analyses of a quality control sample included on each plate, ranged from 4 
to 6% for the genes analysed.  Between plate coefficients of variation for the quality control sample 
ranged from 2 to 11%. The calculated expression values for each gene of interest within each 
sample analysed were normalised first against the corresponding expression values for the 
reference gene (POLR2A) for each sample and then against the mean normalised expression level 
for the control group.  
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Table 1 Real-time-RT qPCR primer and probe sequences, amplicon lengths and mRNA variants amplified 
Gene  
POLR2A 
 
Forward primer 5’ GCAAATTCACCAAGAGAGACG 3’ 
Reverse primer 5’ CACGTCGACAGGAACATCAG 3’ 
Probe 5’ [FAM]CCTGGAGC[TAMRA] 3’ 
Amplicon length 73 nucleotides 
mRNA variants amplified NM_000937.4 
  
DMT-1 (SLC11A2) 
 
Forward primer 5’ GATGTAGAGCATCTAACAGGGATGAA 3’ 
Reverse primer 5’ CCATTGGCAAAGTCACTCATTACT 3’ 
Probe 5’ [FAM]TCTACAGAGCTTACAGCTTCCCTTTGCTCT[TAMRA] 3’ 
Amplicon length 128 nucleotides 
mRNA variants amplified NM_001174125.1, NM_001174126.1, NM_001174127.1, NM_000617.2, 
NM_001174128.1, NM_001174129.1, NM_001174130.1 
  
FPN (SLC40A1) 
 
Forward primer 5’ GCCCATAATCTCTGTCAGTCTGC 3’ 
Reverse primer 5’ TGCCTCTTTCAGATTCAATTACATTT 3’ 
Probe 5’ [FAM]AATCAAAGGACCAAAGACCGATTCTAGCA[TAMRA] 3’ 
Amplicon length 122 nucleotides 
mRNA variants amplified XM_005246504.1, XM_005246505.1 
  
TfR-1 (TFRC) 
 
Forward primer 5’ GCTTTCCCTTTCCTTGCATATTCT 3’ 
Reverse primer 5’ GGTGGTACCCAAATAAGGATAATCTG 3’ 
Probe 5’ [FAM]ATCCCAGCAGTTTCTTTCTGTTTTTGCGA[TAMRA] 3’ 
Amplicon length 87 nucleotides 
mRNA variants amplified NM_001128148.1, NM_003234.2 
 
 
Microarray analysis 
Biotin labelled cDNA was prepared from RNA samples (5 samples for each treatment) using the 
GeneChip Expression 3’ Amplification OneCycle Target labelling kit (Affymetrix). Each cDNA 
sample was hybridized to a separate Affymetrix human GeneChip® array custom made for NuGO 
(www.nugo.org) by ServiceXS (Leiden, Netherlands) using the manufacturer’s standard protocols. 
The experimental details and array data are available in MIAME-compliant format from the 
ArrayExpress database (accession number E-MTAB-3442). 
 
Preparation of whole cell and cell-surface enriched protein extracts 
On day 21, after the different experimental treatments, the medium was removed from the 
Transwells and the Caco-2 monolayers were washed briefly twice with ice-cold phosphate buffer 
saline solution (PBS). Sulfo-NHS-biotin (Thermo Scientific, Loughborough, UK) at a concentration of 
0.25mg/ml in ice-cold PBS was added to the Transwells and the plates gently agitated at 4°C for 30 
minutes. The solution was removed and the cells washed twice with PBS. A solution of 50mM 
iodoacetamide in PBS was added to the Transwells to quench any remaining biotinylation reagent 
activity. The cells were washed twice with PBS and then lysed with ice-cold RIPA buffer (25mM 
Tris-HCl (pH 7.6), 150mM NaCl, 1% v/v NP-40, 1% w/v sodium deoxycholate, 0.1% w/v SDS) 
containing Halt protease & phosphatase inhibitor cocktail (both from Thermo Scientific, 
Loughborough, UK). The cell monolayers were disrupted by scraping and the cell suspensions were 
sonicated. The lysates were centrifuged at 12,000g for 10 minutes at 4°C and the supernatant 
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stored in aliquots at -80 °C. The protein concentration of the extracts was determined using the 
MicroBCA kit (Thermo Scientific, Loughborough, UK) according to the manufacturer’s instructions. 
 
For the preparation of fractions enriched for biotinylated proteins, 2.5 ml of streptavidin agarose 
suspension (Sigma, Poole, UK) was washed three times with PBS, centrifuging at 16,200g for 2 
minutes between each wash to sediment the agarose and allow for removal of the PBS wash. The 
agarose was finally resuspended in PBS to a final total volume of 2 ml. Aliquots of the protein 
extracts (500 µg each) were diluted to 1ug/ul with RIPA buffer.  Streptavidin agarose suspension 
(80µl) was added to each extract and incubated overnight at 4°C on a rotating shaker. The samples 
were centrifuged at 16,200g, 4 °C for 2 minutes and the supernatant was discarded. The agarose 
was washed three times with ice-cold PBS. After the final wash, the beads were suspended in 50µl 
LDS sample buffer (prepared by mixing 200ul of 4x NuPAGE LDS stock solution, 40ul NuPAGE 
reducing agent (both from Life Technologies, Paisley, UK) and ultrapure water at a ratio of 5:1:14). 
The solutions were heated at 90°C for 10 minutes then immediately centrifuged at 16,200g for 2 
minutes. The supernatants were removed to fresh tubes ready for gel electrophoresis. 
 
Western blot analyses 
Aliquots of whole cell protein extracts or biotin-enriched protein fractions were electrophoresed on 
NuPAGE 4-12% Bis Tris gels according to the manufacturer’s instructions (Life Technologies, 
Paisley, UK). Proteins in the gels were transferred to Hybond LFP membrane using Novel XCell II™ 
blot systems according to the manufacturer’s instructions (Life Technologies, Paisley, UK). 
Membranes were incubated with gentle agitation for 1 hour at room temperature in Tris buffered 
saline containing 1% v/v Tween-20 (TBST) and 2% w/v ECL advance blocking agent (Life 
Technologies, Paisley, UK). One set of blots was incubated overnight at 4°C with gentle agitation 
with mouse monoclonal anti-TfR-1 at a final dilution of 1:500 and rabbit polyclonal anti-β-actin at a 
final dilution of 1:10,000 (ab57723 and ab8227, respectively, Abcam, Cambridge, UK) in TBST 
containing 2% w/v ECL advance blocking agent. Another set of blots was incubated in the same 
manner with rabbit polyclonal anti-FPN (MTP11-A, Alpha Diagnostics International) at a final dilution 
of 1:1,000 and mouse monoclonal anti-β-actin (ab8226 Abcam) at a final dilution of 1:2500. 
Following incubations with the primary antibodies, the blots were washed extensively with TBST. 
The blots were then incubated for 1 hour at room temperature with Cy dye labelled secondary 
antibodies (Life Technologies, Paisley, UK). For the blots on which TfR-1 was being detected Cy5 
goat anti-mouse IgG and Cy3 goat anti rabbit IgG antibodies were used, each at a final dilution of 
1:2500 in TBST.  For the blots detecting FPN, Cy5 goat anti-rabbit IgG and Cy3 goat anti-mouse 
IgG antibodies were used, each at a final dilution of 1:2500.  The blots were washed extensively 
with TBST and then finally with TBS. After drying, the blots were scanned using a Pharos FX Plus 
Molecular Imager (Bio-Rad, Hemel Hempstead, UK) at 50µm using a 532nm Excitation laser and a 
605nm BP emission filter for Cy3 and a 695nm Excitation laser and a 635nm BP emission filter for 
Cy5. Florescent signal intensities for TfR-1 and FPN were normalized first against the signal 
intensity for β-actin and then against the average normalized value for the control group. 
 
Statistical analysis 
Data are presented as means ± standard deviation. All datasets were first analysed using the 
D'Agostino & Pearson omnibus normality test or the Kolmogorov-Smirnov, where groups were too 
small to permit use of the former. In those cases where these tests suggested the data were 
normally distributed, one-way ANOVA was employed to make comparisons between treatment 
groups with Tukey’s test for post hoc comparisons when the ANOVA indicated a significant effect of 
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treatment (p<0.05). For datasets that failed the tests for normality, equivalent non-parametric tests 
(Kruskal-Wallis and Dunn's multiple comparisons test) were used. 
 
For the microarrays, data quality was evaluated, and statistical comparisons between treatments 
were performed, using a dedicated software pipeline (De Groot et al. 2008). The data were 
normalized using the GC-RMA method with “full model” option. Only genes with a normalised signal 
≥ 20 on at least 3 arrays were considered to be expressed and included in the subsequent statistical 
analysis.  Gene expression profiles were compared between control cells and cells exposed to 
apical ferric NTA or basolateral Tf using unpaired t-tests with Bayesian correction (Limma) applying 
the false discovery rate (FDR) control method for multiple testing (Smyth 2004). Functional 
relationships between genes identified through the statistical analysis were investigated using 
DAVID Bioinformatic Resources 6.7 (Huang da et al. 2009a; Huang da et al. 2009b) using default 
settings and applying a FDR cut-off value of <0.25. 
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Results 
Routine monitoring of TEER suggested that, under the standard culture conditions used, intact 
polarized cell monolayers with tight junctions were typically obtained 10-12 days following seeding 
of the Caco-2 cells into the inserts (data not shown). This indicated that it should be possible to 
obtain the desired directional supply or iron to either apical or basolateral surface of the cells if the 
supply was initiated on day 14 post-seeding. To determine whether cellular differentiation and 
maturation of the iron transport machinery had completed or was still ongoing from day 14 onwards, 
levels of mRNA for TfR-1, DMT-1 and FPN were determined by real time RT-qPCR in the Caco-2 
cells between day 10 and 21 post-seeding. TfR-1 mRNA levels remained very consistent between 
day 10 and 21 post seeding (Fig 1A). Levels of DMT-1 mRNA appeared to increase to reach a 
maximum at day 17 although the differences did not achieve statistical significance (Fig 1B). Levels 
of FPN mRNA increased steadily over the entire timeframe (Fig 1C) and were significantly higher at 
days 17 (p<0.01), 19 (p<0.05) and 21 (p<0.001) compared with day 10 and at day 21 compared 
with both day 12 and 14 (p<0.05 in both cases). Taken together, these data suggest that some 
establishment of the iron transport machinery was still ongoing during the third week following cell 
seeding although initial the initial stages may have started before an intact cell monolayer had fully 
formed.  
 
 
Fig1 Expression of iron transport genes in Caco-2 cells over time following cell seeding in Transwell® permeable support 
plates. Values shown indicate relative mRNA levels for (A) TfR-1, (B) DMT-1 and (C) FPN in Caco-2 cells determined at 
different days ranging from 10 to 21 post-seeding cultured with normal medium.  Bars and error bars indicate mean + 
standard deviation (n = 4 comprised of samples generated from 1 well from each of 2 separate plates set up in parallel in 
2 independent experiments). Data were compared by one way ANOVA with Tukey’s post-hoc test. Asterisks indicate 
statistically significant differences between days (* p<0.05, ** p<0.01 and *** p<0.001) 
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Based on these observations, cells were treated with either free iron (as ferric NTA) added to the 
upper chamber (corresponding to the apical surface of the cells) or with Tf-bound iron (as human 
holo-Tf)  added to the lower chamber (corresponding to the basolateral surface of the cells) over the 
period from 14 to 21 days after cell seeding. During this time, to reduce the supply of iron to the 
cells from other sources, medium was used that had been prepared with metal-depleted FBS 
prepared by pre-treatment with Chelex resin according to the method of Alvarez-Hernandez and co-
workers (Alvarez-Hernandez et al. 1991). Atomic absorption analysis of the Chelex-treated FBS 
revealed that the iron concentration was reduced to 58% of its original concentration (from 59 to 34 
µM) as a result of this process. There were no significant differences between the different 
treatment groups in the TEER values of the cells layers (online resource 1).   
 
Effects of iron treatments on cellular ferritin levels 
Addition of 30 µM human holo-Tf to the basolateral medium led to a substantial and significant 
(p<0.05) increase in cellular ferritin levels (Fig. 2). Addition of ferric NTA to the apical medium at 2 
µM led to no significant increases in cellular ferritin levels. In marked contrast, addition of 10 µM 
ferric NTA gave rise to very a substantial increase (p<0.0001 compared with controls). There was 
no significant difference between the ferritin concentrations in cell treated with 30 µM basolateral 
holo-Tf and 10 µM apical ferric NTA. Therefore, these concentrations were used in all subsequent 
experiments. 
 
Fig 2 Effects of different forms of iron, supplied to Caco-2 
cell monolayers via either the apical or basolateral surface, 
on intracellular ferritin levels. Values indicate ferritin 
concentrations determined in extracts derived from Caco-2 
cell monolayers that had been established over two weeks 
following seeding in bicameral chambers before being 
swapped for one further week (days 14-21 following cell 
seeding) into medium prepared with metal depleted FBS 
only (Control), medium prepared with metal depleted FBS 
plus 30 µM holo-Tf added to the medium only on the 
basolateral side of the cells (30 µM holo-Tf) or medium 
prepared with metal depleted FBS plus ferric NTA (FeNTA) 
at 2 or 10 µM added to the medium only on the apical side 
of the cells. The bars and error bars indicate mean values 
+ standard deviation (n = 8 comprised of 4 replicate wells 
for each treatment from each of 2 separate plates set up in 
parallel). Data were compared by one way ANOVA with 
Tukey’s post-hoc test. Asterisks indicate statistically 
significant differences between treatments (* p<0.05 and 
**** p<0.0001) 
 
Effects of iron treatments on iron transport activities 
A time course study of the rate of intracellular iron accumulation and trans-cellular iron transport 
across a Caco-2 cell layer 21 days after seeding, under the experimental control conditions used 
here, suggested that both parameters follow an approximately linear increase for at least 3-4 hours 
(online resource 2). We chose to sample at the 2 hour time point in subsequent experiments as this 
was typically the earliest time point at which sufficient basolateral iron had accumulated to enable 
accurate quantification. Analysis of iron uptake and transport following the treatment period from 
day 14 to 21 revealed that these two different modes of supplying iron to the cells exerted distinct 
effects on the cellular iron transport capacities. Apical supply of ferric NTA led to a subsequent 
decrease in the total amount of amount of apical iron uptake by the cells, calculated as the sum of 
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iron retained within the cells and iron transferred from the apical to basolateral medium (p<0.05 
compared with control group), whereas the exposure to basolateral holo-Tf over the same time 
course had no effect on the total iron uptake (Fig. 3). In contrast, basolateral holo-Tf treatment 
significantly reduced subsequent iron transport from the apical to basolateral side of the cell 
monolayer (p<0.01 compared both with control cells and cells exposed to apical ferric NTA) 
whereas exposure to apical iron over the same period had no detectable effect on this parameter 
(Fig. 3). 
 
 
 
Fig 3 Effects of treatment of Caco-2 cell monoloayers with a basolateral supply of holo-Tf or an apical supply of ferric NTA 
on subsequent iron transport across the cell layer. Values shown indicate (A) total cellular iron uptake (sum of iron 
retained within the cells and iron transported from the apical to the basolateral medium) and (B) apical to basolateral iron 
transport of iron supplied to the apical side of the Caco-2 cell monolayer on day 21, following incubation from day 14 to 21 
with medium containing metal depleted FBS in the absence of any added iron (Control),  presence of 10 µM ferric NTA 
added to the apical side of the cells only (10 µM FeNTA) or of 30 µM holo-Tf added to the basolateral side of the cells only 
(30 µM holo-Tf). Bars and error bars indicate mean + standard deviation (n = 8 comprised of 4 replicate wells for each 
treatment from each of 2 separate plates set up in parallel). Data were compared by one way ANOVA with Tukey’s post-
hoc test. Asterisks indicate statistically significant differences between treatments (* p<0.05 and ** p<0.01) 
 
Effects of iron treatments on iron transporter mRNA levels 
To investigate the molecular basis for these effects we examined the expression of the iron 
transporters TfR-1, DMT-1 and FPN at the level of mRNA. TfR-1, DMT-1 and FPN mRNAs were all 
decreased moderately but significantly by the basolateral holo-Tf treatment (p<0.0001 for TfR-1 
compared with control, p<0.05 for both DMT-1 and FPN compared with control) whereas the apical 
ferric NTA treatment had no significant effect on the mRNA levels for any of these genes (Fig. 4).  
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Fig 4 Effects of treatment of Caco-2 cell monoloayers with a basolateral supply of holo-Tf or an apical supply of ferric NTA 
on mRNA levels for iron transport genes. Values shown indicate relative mRNA levels for (A) TfR-1, (B) DMT-1 and (C) 
FPN in Caco-2 cells determined at day 21 post seeding following incubation from day 14 to 21 of confluent Caco-2 cell 
monolayers established in bicameral chamber with medium containing metal depleted FBS in the absence of any added 
iron (Control),  presence of 10 µM ferric NTA added to the apical side of the cells only (10 µM FeNTA) or of 30 µM holo-Tf 
added to the basolateral side of the cells only (30 µM holo-Tf ).  Bars and error bars indicate mean + standard deviation (n 
= 10 comprised of samples generated from 1 or 2 wells for each treatment from each of 3 separate plates set up in parallel 
with a total of 5 samples from each of 2 independent experiments). Data were compared either by Kruskal-Wallis test with 
Dunn’s multiple comparison post-hoc test (for DMT-1 and TfR-1 where at least one data set did not pass the D'Agostino & 
Pearson omnibus normality test) or by one way ANOVA with Tukey’s post-hoc test (for FPN). Asterisks indicate 
statistically significant differences between treatments (* p<0.05, ** p<0.01 and *** p<0.001) 
 
Effects of iron treatments on whole cell and cell surface iron transporter protein expression 
The effects of the different treatments on the whole cell and cell surface levels of TfR-1 and FPN, 
the proteins responsible for moving iron across the basolateral membrane, were also investigated. 
Whole cell levels of TfR-1 protein mirrored the patterns observed for TfR-1 mRNA expression. 
Basolateral supply of holo-Tf led to a moderate but nonetheless significant decrease in whole cell 
TfR-1 protein levels compared to controls (p<0.05) while the levels in cells treated with apical ferric 
NTA were intermediary between controls and those treated with basolateral holo-Tf but were not 
significantly different to either (Fig. 5A). Intriguingly, the analysis of TfR-1 protein levels at the cell 
surface, as assessed by enrichment of the biotinylated protein fraction following treatment of intact 
cells with a protein biotinylating reagent, revealed a rather different pattern. There were no 
significant differences between cell surface levels of TfR-1 in cells treated with basolateral holo-Tf 
and controls. However, treatment of the cells with apical ferric NTA led to a small but significant 
reduction in the amount of TfR-1 at the cell surface (p<0.01 compared with both the control and 
basolateral holo-Tf groups) (Fig. 5B). 
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Fig 5 Effects of treatment of Caco-2 cell monoloayers with a basolateral supply of holo-Tf or an apical supply of ferric NTA 
on whole cell and cell surface levels of proteins responsible for transport of iron across the basolateral membrane of 
enterocytes. Relative protein levels for whole cell TfR-1 (A), cell surface TfR-1 (B), whole cell FPN (C) and cell surface 
FPN (D) in Caco-2 cells determined at day 21 post seeding following incubation from day 14 to 21 of confluent Caco-2 cell 
monolayers established in bicameral chamber with medium containing metal depleted FBS in the absence of any added 
iron (Control),  the presence of 10 µM ferric NTA added to the apical side of the cells only (10 µM FeNTA) or 30 µM holo-
Tf added to the basolateral side of the cells only (30 µM holo-Tf). Insets above each graph depict and an example of the 
one of the Western blots from which the data for the graph were generated. Bars and error bars in the graphs indicate 
mean + standard deviation (n = 6 comprised of samples generated from 2 wells for each treatment from each of 3 
separate plates set up in parallel). Data were compared by one way ANOVA with Tukey’s post-hoc test. Asterisks indicate 
statistically significant differences between treatments (* p<0.05 and ** p<0.01) 
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The pattern of FPN protein levels in whole cell extracts was also similar to the pattern of FPN mRNA 
levels although for the protein analysis no significant differences were observed between any of the 
groups (Fig. 5C). When cell surface levels of FPN protein were analysed, levels were found to be 
significantly lower in the cells treated with basolateral holo-Tf compared with those treated with 
apical ferric NTA (p<0.05) (Fig. 5D). 
 
Effects of iron on gene transcript profiles 
The wider impact of supplementation with apical iron or basolateral holo-Tf on Caco-2 gene 
transcript profiles in Caco-2 cells was examined by microarray analysis of RNA samples extracted 
on day 21 at the end of the iron supplementation period (5 samples for each treatment group were 
analysed each on separate arrays). When a conservative FDR cut-off of <0.05 was applied for the 
statistical comparison of the genes transcript profiles, 7 genes were identified as differentially 
expressed in cells treated with basolateral holo-Tf compared with controls (Table 2) and there were 
no differences detectable between the cells treated with apical ferric NTA and controls. This 
suggests that neither iron treatment elicited widespread and substantial changes in overall patterns 
of gene expression at the level of RNA. A less conservative statistical analysis, performed without 
applying the FDR control (i.e. uncorrected p<0.05), was used to generate gene lists for functional 
annotation enrichment analysis with the DAVID Bioinformatics resource 6.7. This approach 
produced lists of 605 and 443 genes for cells treated with basolateral holo-Tf and apical ferric NTA, 
respectively, compared with controls. A relatively small number of biological pathways or processes 
were identified as significantly enriched in these gene lists (FDR<0.25) (online resource 3). The 
analysis highlighted enrichment of genes involved in a number of lipid metabolic processes in 
response to basolateral holo-Tf treatment whereas the apical ferric NTA appeared to affect 
expression of a number of categories of nuclear proteins. 
 
Table 2 Genes differentially expressed in response to addition of holo-Tf to the basolateral medium of confluent Caco-2 
cell monolayers from day 14 to day 21 after cell seeding.   
Affymetrix 
Probeset ID 
Gene  Gene 
symbol 
Fold 
change
1
 
Uncorrected 
P value
2
 FDR
3
 
226837_at Sprouty-related, EVH1 domain containing 1 SPRED1 2.19 9.77E-06 0.016 
208891_at Dual specificied phosphatase 6 DUSP6 1.51 1.01E-05 0.016 
232321_at Mucin 17 MUC17 3.61 6.50E-06 0.016 
227246_at Pleotropic regulator 1 PLRG1 -1.79 1.05E-05 0.016 
209101_at Connective tissue growth factor CTGF 1.64 6.89E-06 0.016 
208383_s_at Phosphoenolpyruvate carboxykinase 1 PCK1 2.00 4.32E-06 0.016 
211357_s_at Aldolase B ALDOB 1.48 2.10E-05 0.027 
  
1
 Positive values indicate increased expression following holo-Tf treatment (mean expression in holo-Tf treated cells / 
mean expression in controls). Negative values indicate decreased expression following holo-Tf treatment (- mean 
expression in control cells / mean expression in holo-Tf treated cells).  
2
 Derived from unpaired t-tests with Bayesian correction (Limma) comparing data from microarrays for holo-Tf treated and 
control cells (n=5 for both treatments) 
3
 False discovery rate  
 
 
DMT-1 and TfR-1 were amongst the genes identified using the less stringent statistical analysis. 
The data for these genes generally corresponded with the results obtained independently by real 
time RT-qPCR. DMT-1 mRNA levels were significantly reduced in holo-Tf treatment cells compared 
with controls (p<0.05) and TfR-1 levels were lower in holo-Tf treated cells compared with both 
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controls and cells treated with apical ferric NTA (p<0.05). Inspection of the microarray data for 
expression FPN revealed that mean levels of FPN mRNA were lowest in the holo-Tf treated cells, 
although there were no statistically significant differences. There were also no significant differences 
in mRNA levels between any of the treatment groups for other genes involved in iron transport such 
as cytochrome b reductase 1 or hephaestin or in the mRNA levels of ferritin light and heavy chain. 
Equally, mRNA levels of common markers of cell differentiation, such as lactase, sucrose 
isomaltase, dipeptidyl peptidase IV and intestinal alkaline phosphatase (Ferruzza et al. 2012b; 
Jumarie and Malo 1991; Sambuy et al. 2005), did not differ between the treatment groups 
suggesting that the iron treatments had not led to differences in iron transport as a result of 
changing the rate or extent of the differentiation process. 
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Discussion 
The differentiation of enterocytes along crypt-villus axis involves, amongst many other changes, the 
coordinated activation of cellular machinery for iron absorption (Canonne-Hergaux et al. 1999; 
Donovan et al. 2000; Vulpe et al. 1999). It has been postulated that systemic iron status during the 
differentiation process ultimately programmes the iron uptake and transport capacity of mature villus 
enterocytes (Charlton et al. 1965; Conrad et al. 1964; Waheed et al. 2002).  However, since the 
identification of hepcidin as the primary iron stores regulator, this concept has been challenged and 
the current prevailing opinion is that the iron transport capacity of villus enterocytes may be acutely 
regulated by circulating hepcidin levels rather than pre-programmed during differentiation (Frazer et 
al. 2004). Nonetheless, numerous studies have demonstrated that the iron status of enterocytes can 
affect their iron transport capacity, suggesting that this could be an additional modulatory 
mechanism (Gangloff et al. 1996; Nunez et al. 1996; Sharp et al. 2002; Tallkvist et al. 2000; Tallkvist 
et al. 2003).  
 
We employed the Caco-2 cell model of the gut epithelium to compare the effects of iron loading 
from different sources during differentiation on subsequent iron transport activities and transporter 
gene expression. After growing to confluence on permeable membrane supports, Caco-2 cell 
monolayers undergo morphological and functional differentiation that corresponds with many 
aspects of normal enterocyte differentiation, including activation of genes involved in the transport of 
iron across the cell layer (Pinto et al. 1983; Sharp et al. 2002; Tremblay et al. 2006).  The time taken 
following seeding for Caco-2 cells to reach confluence and differentiate depends on a number of 
factors including the source and passage number of the cells, the cell seeding density, the culture 
conditions and the marker or markers of differentiation used (Ferruzza et al. 2012a; Pinto et al. 
1983; Sambuy et al. 2005; Zucco et al. 2005). Analysis of the pattern of iron transporter gene 
expression over time following cell seeding in our cell culture system indicated that while some of 
the initial up-regulation of DMT-1 and FPN mRNA levels may occur prior to the formation of an 
intact monolayer, the process appeared to continue beyond the formation of the intact monolayer 
thus making it possible to supply iron to the cells during the latter stages of differentiation in a 
direction-specific manner.  
 
Ferric NTA was supplied only to the apical side of the cells to represent dietary iron or holo-Tf was 
supplied only to the basolateral side to represent systemic iron. The effects of these different forms 
of iron supply on cellular iron status were evaluated by analysis of cellular ferritin levels. The cellular 
ferritin content of Caco-2 cells is known to be sensitive to iron supply and has been used widely as 
an indirect marker of the cellular iron content of Caco-2 cell systems (Arredondo et al. 1997; 
Gangloff et al. 1996; Glahn et al. 1998; Martini et al. 2002). In line with previous reports, substantial 
increases in cellular ferritin content were observed following both forms of iron exposure, indicating 
that the cells were proficient at taking up both free iron at their apical surface and Tf-bound iron at 
their basolateral surface (Nunez et al. 1996). The levels of cellular ferritin were similar at the end of 
both treatments, suggesting that the cells had achieved similar levels of iron loading. Since iron 
saturated holo-Tf has two atoms of iron bound per protein molecule, the total iron concentration 
used for the basolateral supply of holo-Tf (30 µM holo-Tf, equivalent to 60 µM iron) was 6-fold 
higher than the iron concentration used for the apical treatment of cells with ferric NTA (10 µM). This 
might appear to suggest that, on a molar basis, the ferric NTA was taken up by the cells more 
efficiently than the iron from the holo-Tf, contrary to previous observations (Nunez et al. 1996). 
However, preliminary experiments in which other concentrations of iron were tested had indicated 
that treatment with lower holo-Tf concentrations (10 µM) over the same seven day period led to only 
marginally, and not significantly, lower cellular ferritin than the 30 µM treatment (data not shown), 
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suggesting a non-linear dose response with both 10 and 30 µM basolateral holo-Tf achieving levels 
of cellular ferritin similar to that obtained with the apical ferric NTA.  
 
Ionic iron transported across the apical membrane via DMT-1 and Tf-bound iron taken up by 
endocytosis of TfR-1 at the basolateral membrane feed iron into the labile iron pool, which regulates 
ferritin levels via the activity of IRP-IRE system, in different ways with different dynamics. While it is 
plausible that, after seven days of the two iron treatments, the Caco-2 cells had achieved a new 
steady state of iron status for which ferritin protein levels are a good indicator, we cannot rule out 
the possibility that the different pathways of iron uptake lead to differences in iron partitioning 
between intracellular pools that could play a role in the differences observed in iron transport. 
 
Having identified suitable conditions to iron load the cells, the effects on iron transport were 
investigated. The basolateral supply of holo-Tf during the cellular differentiation phase led to a 
reduction of approximately 50% in subsequent net iron transport from the apical to basolateral side 
of the cells. This occurred in the absence of any apparent change in iron uptake by the cells from 
apical the medium. These data suggest that the effect of the basolateral supply of holo-Tf was 
specifically to decrease iron export across the basolateral membrane. In contrast, ferric iron 
supplied to the apical surface of the cells during differentiation led to a moderate (approximately 
33%) reduction in net total iron uptake without altering the amount of iron transported across the cell 
layer from the apical to the basolateral compartment. This latter observation is similar to the effect 
observed in at least one previous study where Caco-2 cells were loaded with iron (Gangloff et al. 
1996). However, other groups have reported that loading of Caco-2 cells with iron leads to 
decreases in both iron uptake at the apical membrane and export across the basolateral membrane 
(Nunez et al. 1996; Tallkvist et al. 2000; Tallkvist et al. 2003). The variations between these studies 
may result from the use of different forms and concentrations of iron, differences in media 
composition and variation in the treatment duration and the state of differentiation of the cells when 
the iron loading commenced. One of the most critical considerations, in this regard, is that the ferric 
NTA in the experiments described here was supplied only to the apical surface of the cells whereas 
in most previous studies the medium on both sides of the cells was supplemented with iron. Nunez 
and co-workers have demonstrated that Caco-2 cells are capable of taking up ferrous iron at both 
the apical and basolateral surfaces and they and other have demonstrated that iron intake leads to 
a redistribution of iron transporters (Johnson et al. 2005; Nunez et al. 2010; Sharp et al. 2002). It is, 
therefore, plausible that supply of iron to only one surface of the cells may elicit a pattern of 
transporter redistribution that differs from that obtained when iron is added to both sides. 
 
We sought to gain further insight into the basis for these different effects on iron transport first by 
analysing the expression of the iron transporter genes both at the level of the mRNA and the 
protein. The supply of basolateral holo-Tf to the cells during differentiation was associated with 
moderate reductions in the mRNA levels of TfR-1, DMT-1 and FPN, whereas the supply of iron to 
the apical surface had no significant effect on any of these genes. The latter was a somewhat 
unexpected result since there is considerable evidence that all three of these genes can be 
regulated by cellular iron status (Gunshin et al. 2001; Martini et al. 2002; Sharp et al. 2002; Tallkvist 
et al. 2000; Tallkvist et al. 2001; Tallkvist et al. 2003; Zoller et al. 2002). Ferritin and TfR-1 are the 
classic examples of genes regulated in opposing directions via the IRP-IRE system. Expression of 
DMT-1 and FPN may also be regulated, in part, by this system. At least four mRNA splice variants, 
which differ in their first and last exons, are synthesized from the DMT-1 gene in duodenum and in 
Caco-2 cells. In two of these the last exon includes an IRE, which contributes to, but does not 
appear to be the only mechanism for, the iron-responsive regulation of DMT-1 gene transcript levels 
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(Hubert and Hentze 2002; Zoller et al. 2002). In the experiments described here, the primers and 
probe used for the real time RT-qPCR analysis of DMT-1 were designed to amplify all the splice 
variants so as to obtain an overview of total mRNA levels for this gene. However, this does mean 
that it would not have been possible to detect changes specific to individual variants.   
 
The mRNA for FPN also contains an IRE in its 5’ untranslated region, akin to the structure found in 
the ferritin mRNAs and shown to bind IRP in vitro. However, the functionality of this element 
appears to be splice variant and tissue specific (Eisenstein and Ross 2003). For example, duodenal 
epithelial cells and erythroid precursor cells have been shown to expresses a variant form of the 
FPN mRNA lacking the IRE, thus enabling them to avoid suppression of FPN expression under iron 
deficient conditions (Zhang et al. 2009). In fact, enterocyte FPN expression has been found to 
increase under conditions of iron depletion and decrease with iron loading (Martini et al. 2002; Zoller 
et al. 2002) suggesting that other, most likely transcriptional (Zoller et al. 2002), mechanisms are 
predominantly responsible for regulation of the expression of this gene. 
 
While the patterns of total cellular TfR-1 and FPN protein levels following the different treatments 
matched the pattern of the corresponding mRNAs, a rather different picture was obtained when the 
levels of these transporters at the cell surface were analysed. Apical ferric NTA treatment appeared 
to reduce the number of TfR-1 molecules at the cell surface while the basolateral holo-Tf had no 
detectable effect. Apical ferric NTA moderately increased the level of FPN at the cell surface while 
basolateral holo-Tf reduced FPN cell surface levels moderately such that, while neither group 
differed significantly from the control group, the levels in cells exposed to apical ferric NTA were 
significantly lower than those in cells treated with basolateral holo-Tf. Unfortunately, we failed to 
obtain Western blot data of sufficient quality to quantify whole cell and cell surface DMT-1 protein 
levels. However, Nunez and co-workers have demonstrated previously that supply of iron to the 
apical surface of Caco-2 cells leads to rapid internalization of DMT-1 away from the brush-border 
membrane and that iron feeding of rats leads to redistribution of DMT-1 from the apical into basal 
cytoplasmic domains of enterocytes in the duodenum (Nunez et al. 2010). Taken together, these 
observations support the hypothesis that the supply of iron to the apical surface of Caco-2 cells 
caused the down-regulation of iron uptake as a result of redistribution of DMT-1 away from the 
apical surface of the cells while supply of holo-Tf to the basolateral surface of the cells decreased 
iron transport via a combination of supressed FPN expression and its redistribution away from the 
basolateral surface of the cells. However, one limitation of the method used in the current study to 
quantify cell surface expression is that the apical and basolateral surface of the cells were treated 
with the biotinylating reagent simultaneously. As a result, it is not possible to determine from these 
data the relative levels of the iron transporters at the apical and basolateral surfaces. In 
differentiated Caco-2 cells grown on permeable membrane supports, TfR-1 appears to be found 
almost exclusively in the basolateral region (Nunez et al. 2010). On the other hand, as noted above, 
there is evidence that DMT-1, and also FPN, may be found at both the apical and basolateral cell 
surfaces in differentiated Caco-2 cell monolayers grown on permeable membrane supports) and 
that iron supply can cause redistribution of both transporters across these surfaces (Nunez et al. 
2010).  FPN located within the apical membrane could affect the apparent rate of iron uptake by 
exporting some back into the apical medium. DMT-1 within the basolateral membrane provides a 
potential mechanism for reabsorption of iron from the basolateral medium. Redistribution of these 
transporters between the apical and basolateral membranes could contribute to the changes in iron 
transport observed following exposure of the cells to basolateral holo-Tf or apical ferric NTA by 
altering the rate of iron uptake at the apical surface and export at the basolateral surface. It could 
also alter the rate of export of iron from the cell back into the apical medium and reabsorption of iron 
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from the basolateral medium back into the cells. Given that the changes in mRNA for DMT-1 and 
FPN and total protein levels for FPN were small, it is likely that redistribution of one or both of these 
transporters contributes to the changes in iron transport observed. 
 
We used microarray analysis to investigate the wider impact of the two iron treatments on the Caco-
2 cells. The results indicated that both apical ferric NTA and basolateral supply of holo-Tf elicited 
relatively minor changes in gene expression patterns. Applying stringent statistical criteria 
(FDR<0.05), no genes were identified as being differentially regulated in response to apical ferric 
NTA while just seven genes were identified as being differentially expressed in response to 
basolateral holo-Tf supply. Of these seven, four play roles in key cellular functions such as growth, 
differentiation and cell death. Sprouty-related EVH1 domain containing 1 (SPRED1) and dual 
specificity phosphatase 6 (DUSP6) are negative regulators of MAP kinase signalling (Gonzalez-
Sarrias et al. 2009; Quintanar-Audelo et al. 2011). Pleotropic regulator 1 (PLRG1) is a component of 
the spliceosome that appears to be involved in regulation of proliferation and apoptosis (Kleinridders 
et al. 2009) and connective tissue growth factor (CTGF) regulates processes such as mitosis, 
adhesion, apoptosis and migration in many cells (Brigstock 2003). However, the functional 
annotation enrichment analysis of the wider gene lists did not identify significant enrichment for 
groups of genes involved any of these processes and inspection of the array data for established 
markers of Caco-2 cell differentiation revealed no differences between any of the treatments. 
 
Two of the other genes in the list of seven identified as being differentially regulated by holo-Tf 
treatment (phosphoenolpyruvate carboxykinase 1(PCK1) and aldolase B (ALDOB)) are involved in 
glucose metabolism (Ito et al. 1998), while the final one was a mucin (MUC17). The observation of 
increased expression of a mucin following holo-Tf treatment is intriguing since it has been proposed 
that mucins may play an important role in enhancing absorption of dietary iron by helping to 
maintain ionic iron in a soluble form (Conrad et al. 1991). Caco-2 cells have been shown to express 
some mucin genes including MUC17 (Resta-Lenert et al. 2011) but Caco-2 cell monolayers do not 
develop a mucous layer so the significance of this observation is not clear. 
 
Perhaps surprisingly, the functional annotation enrichment analysis did not highlight any processes 
associated with iron or metal homeostasis. Analysis of the microarray data for individual key genes 
involved in iron homeostasis suggested that the iron loading only led to small changes in mRNA 
levels. Nonetheless, clear changes in iron transport across the cell layer were evident, suggesting 
that post-transcriptional regulatory processes are likely to be involved. Thus, in conclusion, while it 
is well known that the iron status of cells can affect their iron transport capacity, this is the first direct 
evidence we are aware of that the form and direction of iron supply to enterocytes may also have 
distinct functional consequences.  
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Online resource 1 
Differential effects of basolateral and apical iron supply on iron transport in Caco-2 cells 
Eady JJ, Wormstone YM, Heaton SJ, Hilhorst B and Elliott RM 
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Effects of different forms of iron, supplied to Caco-2 cell monolayers via either the apical or basolateral 
surface, on transepithelial electrical resistance (TEER) of the cell layer. Values indicate background corrected 
TEER values determined for Caco-2 cell monolayers established over two weeks (days 1-13 following 
seeding) in bicameral chambers before being swapped for one further week (days 14-21 following cell 
seeding) into medium prepared with metal depleted fetal bovine serum (FBS) only (black circles), medium 
prepared with metal depleted FBS plus 30 μM holo-Tf added to the medium only on the basolateral side of 
the cells (open circles) or medium prepared with metal depleted FBS plus 10 μM ferric NTA added to the 
medium only on the apical side of the cells (open squares). The medium was refreshed every 2 to 3 days. 
Error bars indicate mean values ± standard deviation (n = 8 comprised of measurements from 2 replicate 
wells for each treatment from each of 4 separate plates set up in parallel). Data were compared by two way 
ANOVA. The results of this analysis indicated that there was a significant change in TEER values over time 
(p<0.0001) but no significant effects of the treatments and no significant interaction between treatment and 
time.  
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Online resource 2 
Differential effects of basolateral and apical iron supply on iron transport in Caco-2 cells 
Eady JJ, Wormstone YM, Heaton SJ, Hilhorst B and Elliott RM 
 
 
Uptake and transport of iron across Caco-2 cell monolayers over time. Intact cells monolayers were 
established by seeding Caco-2 cells at a density of 30,000 cells/cm
2
 in Transwell® permeable support plates 
(Costar®, Corning Inc., New York, USA) and culturing in normal medium for 21 days, refreshing the medium 
every 2 to 3 days.  On day 21, (A) total iron uptake (calculated as the sum intracellular iron and iron 
transported across the cells to the basolateral medium)  into the cells from apical medium and (B) iron 
transport across the cell layer to the basolateral medium were determined at different time point as 
described in material and methods. Error bars indicate mean  ± standard deviation (derived from 
measurements obtained from 6 separate wells set up 
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Online resource 3 
Differential effects of basolateral and apical iron supply on iron transport in Caco-2 cells 
Eady JJ, Wormstone YM, Heaton SJ, Hilhorst B and Elliott RM 
 
Outputs of functional annotation enrichment analysis performed with the DAVID Bioinformatic Resources 6.7  
 
(A) Comparison of basolateral holo-Tf treatment versus control 
Category Term Count % P Value List Total Pop Hits Pop Total Fold Enrichment FDR 
SP_PIR_KEYWORDS phosphoprotein 275 47.83 6.95E-08 565 7263 19235 1.29 9.88E-05 
GOTERM_BP_FAT GO:0046486~glycerolipid metabolic process 19 3.30 2.49E-06 417 162 13528 3.80 0.004348 
GOTERM_BP_FAT GO:0008610~lipid biosynthetic process 26 4.52 2.21E-05 417 323 13528 2.61 0.038609 
GOTERM_BP_FAT GO:0006641~triglyceride metabolic process 9 1.57 4.21E-05 417 43 13528 6.79 0.07355 
GOTERM_BP_FAT GO:0006644~phospholipid metabolic process 18 3.13 8.00E-05 417 190 13528 3.07 0.139633 
SP_PIR_KEYWORDS disease mutation 74 12.87 8.41E-05 565 1591 19235 1.58 0.119619 
GOTERM_BP_FAT GO:0006639~acylglycerol metabolic process 9 1.57 1.12E-04 417 49 13528 5.96 0.194572 
GOTERM_BP_FAT GO:0006638~neutral lipid metabolic process 9 1.57 1.29E-04 417 50 13528 5.84 0.225467 
 
 
(B) Comparison of apical ferric nitrilotriacetate treatment versus control 
Category Term Count % P Value List Total Pop Hits Pop Total Fold Enrichment FDR 
SP_PIR_KEYWORDS phosphoprotein 213 51.0 2.69E-09 409 7263 19235 1.379216 3.69E-06 
GOTERM_CC_FAT GO:0043233~organelle lumen 70 16.7 1.52E-07 263 1820 12782 1.86926 2.04E-04 
GOTERM_CC_FAT GO:0070013~intracellular organelle lumen 68 16.3 3.16E-07 263 1779 12782 1.857702 4.24E-04 
GOTERM_CC_FAT GO:0031974~membrane-enclosed lumen 70 16.7 3.23E-07 263 1856 12782 1.833003 4.34E-04 
GOTERM_CC_FAT GO:0044451~nucleoplasm part 31 7.4 1.17E-06 263 555 12782 2.714637 0.00157 
GOTERM_CC_FAT GO:0031981~nuclear lumen 57 13.6 1.81E-06 263 1450 12782 1.910513 0.002427 
GOTERM_CC_FAT GO:0016604~nuclear body 15 3.6 9.20E-06 263 168 12782 4.339354 0.012356 
SP_PIR_KEYWORDS acetylation 88 21.1 1.34E-05 409 2635 19235 1.570619 0.018417 
GOTERM_CC_FAT GO:0005654~nucleoplasm 38 9.1 2.40E-05 263 882 12782 2.09391 0.032218 
GOTERM_CC_FAT GO:0016607~nuclear speck 11 2.6 4.87E-05 263 103 12782 5.190372 0.06545 
SP_PIR_KEYWORDS nucleus 124 29.7 1.14E-04 409 4283 19235 1.361578 0.156603 
 
